Form 6-K ASML HOLDING NV For: Oct 19

October 19, 2016 6:49 AM

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
______________________

FORM 6-K

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For October 19, 2016

______________________

ASML Holding N.V.

De Run 6501

5504 DR Veldhoven

The Netherlands

(Address of principal executive offices)

______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

EXHIBITS 99.1, 99.3, AND 99.4 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-142254), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-162439), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-170034), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-188938), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-190023), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-192951) AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-203390) OF ASML HOLDING N.V. AND IN THE OUTSTANDING PROSPECTUSES CONTAINED IN SUCH REGISTRATION STATEMENTS.

Exhibits


99.1	“Strong logic demand drives third-quarter results, on track for record 2016 sales. Orders for three EUV systems show customer base expanding to six”, press release dated October 19, 2016


99.2	“Strong logic demand drives Q3 results, on track for record 2016 sales. Orders for three EUV systems show customer base expanding to six”, presentation dated October 19, 2016


99.3	Summary U.S. GAAP Consolidated Financial Statements


99.4	Summary IFRS Consolidated Financial Statements

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ASML HOLDING N.V. (Registrant)

Date: October 19, 2016 By: /s/ Peter T.F.M. Wennink

Peter T.F.M. Wennink

Chief Executive Officer

Exhibit 99.1

Media Relations Contacts

Lucas van Grinsven - Corporate Communications - +31 6 101 99 532 - Veldhoven, the Netherlands

Niclas Mika - Corporate Communications - +31 6 201 528 63 - Veldhoven, the Netherlands

Investor Relations Contacts

Craig DeYoung - Investor Relations - +1 480 696 2762 - Chandler, Arizona, USA

Marcel Kemp - Investor Relations - +31 40 268 6494 - Veldhoven, the Netherlands

Strong logic demand drives third-quarter results, on track for record 2016 sales

Orders for three EUV systems show customer base expanding to six

VELDHOVEN, the Netherlands, October 19, 2016 - ASML Holding N.V. (ASML) today publishes its 2016 third-quarter results.


•	Q3 net sales of EUR 1.81 billion, gross margin 46.0 percent


•	ASML guides Q4 2016 net sales between EUR 1.7 and 1.8 billion and a gross margin between 47 and 48 percent


•	ASML continues to expect HMI acquisition to close in Q4



(Figures in millions of euros unless otherwise indicated)	Q2 2016	Q3 2016
Net sales	1,740	1,815
...of which service and field option sales	486	577

Other income (Co-Investment Program)	23	23

New systems sold (units)	39	38
Used systems sold (units)	7	2
Average Selling Price (ASP) of net system sales	27.3	31.0

Net bookings	1,566	1,415
Systems backlog	3,371	3,462

Gross profit	741	834
Gross margin (%)	42.6	46.0

Net income	354	396
EPS (basic; in euros)	0.83	0.93

End-quarter cash and cash equivalents and short-term investments	2,926	4,313

A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com

CEO Statement

"As anticipated, our third-quarter sales were driven by logic customers building out the 10 nanometer node, which represented more than 80 percent of net system sales, as well as continued growth in net service and field option sales. We also recognized partial revenue for one EUV system at shipment, which had not been included in our previous guidance. This lifted third-quarter net sales above guidance but also decreased our gross margin by 1.4 percentage points. For the remainder of the year, a mix of sales to both logic and memory customers keeps us on track to finish the year with record annual sales, for the third consecutive year," ASML President and Chief Executive Officer Peter Wennink said.

"Our EUV program continued to make progress on key industrialization metrics and we took orders for three NXE:3400 EUV systems in the quarter. This means that six customers are now actively engaged in the EUV introduction in both memory and logic."

Product and Business Highlights

•

In Deep Ultraviolet (DUV) lithography, we have shipped a total of 38 TWINSCAN NXT:1980 systems since introduction last year, enabling the 10 nanometer logic node ramp. In addition to new system sales, customers also upgrade existing systems to NXT:1980 performance. These upgrades are ramping in volume, supporting revenue growth from our installed base. For customers producing 3D NAND memory chips, we introduced a large-range level sensor as an option to our line of XT “dry” systems in the third quarter. This option improves leveling and hence focus performance on 3D NAND high-topology layers.

•

In Holistic Lithography, we concluded a high-volume, multi-year purchase agreement with a leading chip maker, who will use ASML’s complete suite of Brion process window enhancement products for its high-volume production applications to achieve higher yield at the most advanced nodes. In addition, we successfully rolled out our latest litho control software to both memory and foundry customers in the third quarter. Most regulatory approvals for the acquisition of Hermes Microvision Inc. (HMI) have been received and we continue to expect it to close in the fourth quarter.

•

In Extreme Ultraviolet (EUV) lithography, one of our customers demonstrated an average productivity of more than 1,500 wafers per day (wpd) over three days on a NXE:3350B. The best availability performance shown by an EUV system was above 90 percent over four weeks on a NXE:3300B. We shipped one NXE:3350B system in the third quarter. In Q4, we expect to ship one system; two additional systems will be

delayed into early 2017, one due to customer fab readiness and one due to late material delivery.

Outlook

For the fourth-quarter of 2016, ASML expects net sales between EUR 1.7 and 1.8 billion, a gross margin between 47 and 48 percent, R&D costs of about EUR 275 million, other income of about EUR 23 million -- which consists of contributions from participants of the Customer Co-Investment Program, SG&A costs of about EUR 100 million (which includes one-off acquisition-related costs of around EUR 10 million) and an effective annualized tax rate of around 13 percent.

Update Share Buyback Program

As part of ASML's financial policy to return excess cash to shareholders through dividends and regularly timed share buyback programs, ASML in January 2016 announced its intention to purchase up to EUR 1.5 billion of shares to be executed within the 2016-2017 time frame. ASML intends to cancel the shares upon repurchase.

Through October 2, 2016, ASML has acquired 4.8 million shares under this program for a total consideration of EUR 400 million. The repurchased shares will be canceled.

The share buyback program is currently paused while we are in the midst of the HMI acquisition process. We continue to expect to complete the full 2016-2017 program, yet it may be further suspended, modified or discontinued at any time. Any transactions under this program will be published on ASML's website (www.asml.com/investors) on a weekly basis.

About ASML

ASML is one of the world’s leading manufacturers of chip-making equipment. Our vision is to enable affordable microelectronics that improve the quality of life. To achieve this, our mission is to invent, develop, manufacture and service advanced technology for high-tech lithography, metrology and software solutions for the semiconductor industry. ASML's guiding principle is continuing Moore's Law towards ever smaller, cheaper, more powerful and energy-efficient semiconductors. This results in increasingly powerful and capable electronics that enable the world to progress within a multitude of fields, including healthcare, technology, communications, energy, mobility, and entertainment. We are a

multinational company with over 70 locations in 16 countries, headquartered in Veldhoven, the Netherlands. We employ more than 15,500 people on payroll and flexible contracts (expressed in full time equivalents). ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. More information about ASML, our products and technology, and career opportunities is available on www.asml.com.

Investor and Media Conference Call

A conference call for investors and media will be hosted by CEO Peter Wennink and CFO Wolfgang Nickl at 15:00 PM Central European Time / 09:00 AM U.S. Eastern time. To register for the call and receive dial-in information, go to www.asml.com/qresultscall. Listen-only access is also available via www.asml.com.

US GAAP and IFRS Financial Reporting

ASML's primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States of America. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows and consolidated balance sheets, and a reconciliation of net income and equity from US GAAP to IFRS as adopted by the EU (‘IFRS’) are available on www.asml.com.

In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of share-based payment plans and the accounting of income taxes. ASML’s quarterly IFRS consolidated statement of profit or loss, consolidated statement of cash flows, consolidated statement of financial position and a reconciliation of net income and equity from US GAAP to IFRS are available on www.asml.com.

The consolidated balance sheets of ASML Holding N.V. as of October 2, 2016, the related consolidated statements of operations and consolidated statements of cash flows for the quarter ended October 2, 2016 as presented in this press release are unaudited.

Regulated Information

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

Forward Looking Statements

This document contains statements relating to certain projections and business trends that are forward-looking, including statements with respect to our outlook, including expected customer demand in specified market segments including memory, logic and foundry, expected trends and outlook, including expected levels of service sales, systems backlog, expected financial results for the fourth quarter and full year 2016, including expected sales, other income, gross margin, R&D and SG&A expenses and effective annualized tax rate, annual revenue opportunity for ASML and EPS potential by end of decade, productivity of our tools and systems performance, including EUV system performance (such as endurance tests), expected industry trends and expected trends in the business environment, statements with respect to the acquisition of HMI by ASML, including the expected timing of completion of the HMI acquisition, the expected benefits of the acquisition of HMI by ASML, including the provision of e-beam metrology capability and its effect on holistic lithography solutions and pattern fidelity control, statements with respect to EUV targets, including availability, productivity and shipments, including the number of EUV systems expected to be shipped and timing of shipments, and roadmaps, shrink being key driver to industry growth, expected industry adoption of EUV and statements with respect to the intent of customers to insert EUV into production, the expected continuation of Moore's law and that EUV will continue to enable Moore’s law and drive long term value, goals for holistic lithography, intention to return excess cash to shareholders, and statements about our proposed dividend, dividend policy and intention to repurchase shares and statements with respect to the current share repurchase plan. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about the business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of general economic conditions on consumer confidence and demand for our customers' products, competitive products and pricing, the impact of any manufacturing efficiencies and capacity constraints, performance of our systems, the continuing success of technology advances and the related pace of new product development and customer acceptance of new products including EUV, the number and timing of EUV systems expected to be shipped and recognized in revenue, delays in EUV systems production and development, our ability to enforce patents and protect intellectual property rights, the risk of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates, changes in tax rates, available cash and liquidity, our ability to refinance our indebtedness, distributable reserves for dividend payments and share repurchases and timing of resumption of the share repurchase plan, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Strong logic demand drives Q3 results, on track for record 2016 sales Orders for three EUV systems show customer base expanding to six ASML 2016 Third-Quarter Results Veldhoven, the Netherlands October 19, 2016 Public

Public Slide 2 October 19, 2016 Agenda • Investor key messages • Business highlights • Outlook • EUV highlights • HMI acquisition status • Financial statements

Public Slide 3 October 19, 2016 Investor key messages

Public Slide 4 October 19, 2016 Investor key messages • Lithography enables affordable shrink and therefore delivers compelling value for our customers • ASML’s R&D investments in lithography and process control products supports customer roadmaps • EUV will enable continuation of Moore’s Law and will drive long term value for ASML • DUV and Holistic Litho product roadmaps enable multi-pass immersion patterning today, with Holistic Litho supporting EUV in the future. These highly differentiated products provide unique value drivers for us and our customers • ASML models an annual revenue opportunity of € 10 billion* by 2020 and given the significant leverage in our financial model will allow a potential tripling of EPS* by the end of this decade, compared to calendar year 2014, thereby creating significant value for all stakeholders • We expect to continue to return excess cash to our shareholders through dividends that are stable or growing and regularly timed share buybacks in line with our policy • Planned HMI acquisition provides market leading e-beam metrology capability which expands our integrated Holistic Lithography solutions to include a new class of pattern fidelity control * HMI acquisition not included, see Press Release (date June 16th 2016 on www.asml.com)

Public Slide 5 October 19, 2016 Business highlights

Public Slide 6 October 19, 2016 Q3 results summary • Net sales of € 1,815 million, including around € 85 million EUV, 40 litho systems sold valued at € 1,238 million, net service and field option sales at € 577 million • Average selling price of € 31.0 million per system • Gross margin of 46.0% • Operating margin of 27.3% • Net bookings of € 1,415 million, including 3 new EUV systems • Backlog at € 3,462 million, including 12 EUV systems

Public Slide 7 October 19, 2016 Sales in Units EUV ArF i ArFdry KrF I-Line 1 19 1 14 5 EUV ArF i ArFdry KrF I-Line 2 19 2 16 7 Net system sales breakdown in value Technology EUV 7% ArF Immersion 77% ArF Dry 2% KrF 12% I-line 2% End-Use Memory 16% Foundry 66% IDM 18% Q3’16 total value € 1,238 million Q2’16 total value € 1,254 million EUV 8% ArF Immersion 76% ArF Dry 3% KrF 11% I-line 2% Memory 35% Foundry 40% IDM 25% USA 21% Korea 20% Taiwan 28% China 15% Japan 4% Rest of Asia 8% Europe 4% Region (ship to location) USA 9% Korea 10% Taiwan 55% China 6% Japan 5% Rest of Asia 7% Europe 8%

Public Slide 8 October 19, 2016 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 N et Sa le s 2011 2012 2013 2014 2015 2016 1,452 1,252 892 1,397 1,650 1,333 1,529 1,228 1,187 1,644 1,654 1,740 1,459 1,229 1,318 1,322 1,549 1,815 1,211 5,651 1,023 4,732 1,848 5,245 1,494 1,434 6,287 Total net sales million € by quarter Q4 Q3 Q2 Q1 4,888 YTD 5,856

Public Slide 9 October 19, 2016 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 N et Sa le s 2011 2012 2013 2014 2015 2016 2,184 935 1,489 2,225 2,115 989 844 588 440 831 514 628 1,856 2,279 2,064 1,186 1,608 1,731 767 5,651 930 4,732 1,252 5,245 1,614 5,856 2,050 6,287 1,540 Total net sales million € by End-use 4,888 YTD Service & Options Foundry IDM Memory

Public Slide 10 October 19, 2016 Bookings activity by sector Q3’16 total value € 1,415 million New systems Used systems Units 37 6 Value M€ 1,396 19 New systems Used systems Units 40 3 Value M€ 1,555 11 Q2’16 total value € 1,566 million Memory 36% Foundry 52% IDM 12% Memory 25% Foundry 57% IDM 18%

Public Slide 11 October 19, 2016 System backlog in value Technology EUV 38% ArF Immersion 51% ArF Dry 2% KrF 8% I-line 1% Region (ship to location) USA 29% Korea 27% Taiwan 28% China 5% Rest of Asia 1% Europe 10% End-Use Memory 31% Foundry 40% IDM 29% Q3’16 total value € 3,462 million Q2’16* total value € 3,371 million Memory 22% Foundry 47%IDM 31% USA 26%Korea 22% Taiwan 35% China 5% Japan 2% Rest of Asia 3% Europe 7% New systems Used systems Units 64 12 Value M€ 3,426 36 New systems Used systems Units 65 8 Value M€ 3,335 36 EUV 31% ArF Immersion 59% ArF Dry 2% KrF 7% I-line 1% * End-use distribution of Q2 2016 backlog contains an adjustment which transferred € 141 million from Foundry to Memory

Public Slide 12 October 19, 2016 Capital return to shareholders Progress of 2016/2017 share buyback program for up to € 1.5 billion • Purchased € 13 million worth of shares in Q3 • Year to date € 400 million worth of shares purchased • Share buyback program is currently paused while we are in the midst of the HMI acquisition process Dividend history 1.2 1.0 0.8 0.6 0.4 0.2 0.0 D iv id en d (e ur o) 2008 2009 2010 2011 2012 2013 2014 2015 0.20 0.20 0.40 0.46 0.53 0.61 0.70 1.05 Cumulative capital return as from 2006 8,000 6,000 4,000 2,000 0 € m illi on 2008 2009 2010 2011 2012 2013 2014 2015 2016 Dividend Share buyback The dividend for a year is paid in the subsequent year YTD

Public Slide 13 October 19, 2016 Outlook

Public Slide 14 October 19, 2016 Outlook • Q4 net sales between € 1.7 and 1.8 billion • Gross margin between 47 and 48% • R&D costs of about € 275 million • SG&A costs of about € 100 million (which includes one-off acquisition-related costs of around € 10 million) • Other income (Customer Co-Investment Program) of about € 23 million • Effective annualized tax rate around 13% • Our guidance for fourth-quarter:

Public Slide 15 October 19, 2016 EUV highlights

Public Slide 16 October 19, 2016 EUV 2016 targets and achievements • More than 1,500 wafers per day (wpd) exposed on NXE:3350B at a customer site on average over a three days period • Best performance is four-week average above 90% on one NXE:3300B system • Seven customer systems have achieved a four-week average availability of more than 80% • Consistency between tools and across sites still needs to be improved • One NXE:3350B system shipped in Q1, one NXE:3350B system shipped in Q2, one NXE:3350B shipped in Q3 • In Q4, we plan to ship one system; two additional systems will be delayed into early 2017, one due to customer fab readiness and one due to late material delivery Productivity - Target: 1500 wafers per day Availability - Target: 80% NXE shipments - Target: 6-7

Public Slide 17 October 19, 2016 HMI acquisition status

Public Slide 18 October 19, 2016 HMI acquisition status • HMI shareholders voted in favor for the acquisition during the HMI EGM • Approvals received : • CFIUS (US) • Competition Commission Singapore • Taiwan Fair Trade Commission • Taiwan Investment Commission Inbound • Approval pending : • Taiwan Investment Commission Outbound (private placement) • Korea Fair Trade Commission • ASML continues to expect HMI acquisition to close in Q4 2016

Public Slide 19 October 19, 2016 Financial statements

Public Slide 20 October 19, 2016 Consolidated statements of operations M€ Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Net sales 1,549 1,434 1,333 1,740 1,815 Gross profit 703 660 568 741 834 Gross margin % 45.4% 46.0% 42.6% 42.6% 46.0% Other income* 21 21 23 23 23 R&D costs (267) (273) (275) (270) (273) SG&A costs (86) (90) (89) (90) (89) Income from operations 372 318 228 404 495 Operating income % 24.0% 22.2% 17.1% 23.2% 27.3% Net income 322 292 198 354 396 Net income as a % of net sales 20.8% 20.4% 14.9% 20.3% 21.8% Earnings per share (basic) € 0.75 0.68 0.46 0.83 0.93 Earnings per share (diluted) € 0.75 0.68 0.46 0.83 0.93 Litho units sold 44 37 33 46 40 ASP new litho systems 24.2 26.9 29.5 31.6 32.4 Net booking value 904 1,184 835 1,566 1,415 * Customer Co-Investment Program (CCIP)

Public Slide 21 October 19, 2016 Cash flows M€ Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Net income 322 292 198 354 396 Net cash provided by (used in) operating activities 420 985 (6) 481 (3) Net cash provided by (used in) investing activities (99) (1,078) (183) (24) (484) Net cash provided by (used in) financing activities (133) (131) (204) (607) 1,481 Net increase (decrease) in cash & cash equivalents 186 (222) (395) (137) 987 Free cash flow* 333 864 (65) 381 (72) * Free cash flow is defined as net cash provided by (used in) operating activities minus investments in Capex (Purchase of Property, plant and equipment and intangibles), see US GAAP Consolidated Financial Statements

Public Slide 22 October 19, 2016 Balance sheets M€ Assets Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Cash & cash equivalents and short-term investments 2,681 3,409 3,138 2,926 4,313 Net accounts receivable and finance receivables 1,593 1,208 1,302 1,362 1,593 Inventories, net 2,537 2,574 2,750 2,715 2,697 Other assets 846 940 987 1,146 1,164 Tax assets 203 181 143 228 183 Goodwill 2,574 2,624 2,538 2,603 2,571 Other intangible assets 739 738 706 714 694 Property, plant and equipment 1,533 1,621 1,580 1,609 1,587 Total assets 12,706 13,295 13,144 13,303 14,802 Liabilities and shareholders' equity Current liabilities 2,711 3,107 3,248 3,720 3,272 Non-current liabilities 1,850 1,799 1,593 1,434 3,017 Shareholders' equity 8,145 8,389 8,303 8,149 8,513 Total liabilities and shareholders' equity 12,706 13,295 13,144 13,303 14,802 As of January 1, 2016 ASML early adopted the amendment to ASC 740 “Income taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which requires that deferred tax liabilities and assets are classified as non-current in the consolidated balance sheets. The comparative figures have not been adjusted to reflect this change in accounting policy.

Public Slide 23 October 19, 2016 This document contains statements relating to certain projections and business trends that are forward-looking, including statements with respect to our outlook, including expected customer demand in specified market segments including memory, logic and foundry, expected trends and outlook, including expected levels of service sales, systems backlog, expected financial results for the fourth quarter and full year 2016, including expected sales, other income, gross margin, R&D and SG&A expenses and effective annualized tax rate, annual revenue opportunity for ASML and EPS potential by end of decade, productivity of our tools and systems performance, including EUV system performance (such as endurance tests), expected industry trends and expected trends in the business environment, statements with respect to the acquisition of HMI by ASML, including the expected timing of completion of the HMI acquisition, the expected benefits of the acquisition of HMI by ASML, including the provision of e-beam metrology capability and its effect on holistic lithography solutions and pattern fidelity control, statements with respect to EUV targets, including availability, productivity and shipments, including the number of EUV systems expected to be shipped and timing of shipments, and roadmaps, shrink being key driver to industry growth, expected industry adoption of EUV and statements with respect to the intent of customers to insert EUV into production, the expected continuation of Moore's law and that EUV will continue to enable Moore’s law and drive long term value, goals for holistic lithography, intention to return excess cash to shareholders, and statements about our proposed dividend, dividend policy and intention to repurchase shares and statements with respect to the current share repurchase plan. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about the business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of general economic conditions on consumer confidence and demand for our customers' products, competitive products and pricing, the impact of any manufacturing efficiencies and capacity constraints, performance of our systems, the continuing success of technology advances and the related pace of new product development and customer acceptance of new products including EUV, the number and timing of EUV systems expected to be shipped and recognized in revenue, delays in EUV systems production and development, our ability to enforce patents and protect intellectual property rights, the risk of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates, changes in tax rates, available cash and liquidity, our ability to refinance our indebtedness, distributable reserves for dividend payments and share repurchases and timing of resumption of the share repurchase plan, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward- looking statements, whether as a result of new information, future events or otherwise. Forward looking statements

Exhibit 99.3

ASML - Summary US GAAP Consolidated Statements of Operations ^1,2



	Three months ended,				Nine months ended,
	Sep 27,		Oct 2,		Sep 27,		Oct 2,
	2015		2016		2015		2016
(in millions EUR, except per share data)

Net system sales	975.3		1,238.2		3,356.3		3,348.1
Net service and field option sales	573.9		576.4		1,496.9		1,539.3
Total net sales	1,549.2		1,814.6		4,853.2		4,887.4

Total cost of sales	(845.7	)	(980.2	)	(2,617.3	)	(2,743.5	)
Gross profit	703.5		834.4		2,235.9		2,143.9

Other income	20.8		23.4		62.4		70.3
Research and development costs	(266.3	)	(273.4	)	(795.1	)	(818.4	)
Selling, general and administrative costs	(85.6	)	(88.8	)	(256.2	)	(268.0	)
Income from operations	372.4		495.6		1,247.0		1,127.8

Interest and other, net	(4.2	)	(33.9	)	(11.9	)	(41.1	)
Income before income taxes	368.2		461.7		1,235.1		1,086.7

Benefit from (provision for) income taxes	(45.8	)	(65.8	)	(140.3	)	(139.0	)
Net income	322.4		395.9		1,094.8		947.7


Basic net income per ordinary share	0.75		0.93		2.54		2.23
Diluted net income per ordinary share ³	0.75		0.93		2.52		2.22


Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic	429.9		423.8		431.3		425.1
Diluted ³	432.3		425.8		433.7		427.0

ASML - Ratios and Other Data ^1,2



	Three months ended,				Nine months ended,
	Sep 27,		Oct 2,		Sep 27,		Oct 2,
	2015		2016		2015		2016
(in millions EUR, except otherwise indicated)

Gross profit as a percentage of net sales	45.4	%	46.0	%	46.1	%	43.9	%
Income from operations as a percentage of net sales	24.0	%	27.3	%	25.7	%	23.1	%
Net income as a percentage of net sales	20.8	%	21.8	%	22.6	%	19.4	%
Income taxes as a percentage of income before income taxes	12.4	%	14.2	%	11.4	%	12.8	%
Shareholders’ equity as a percentage of total assets	64.1	%	57.5	%	64.1	%	57.5	%
Sales of systems (in units)	44		40		132		119
Average selling price of system sales (EUR millions)	22.2		31.0		25.4		28.1
Value of systems backlog (EUR millions) ⁴	2,880		3,462		2,880		3,462
Systems backlog (in units)⁴	72		76		72		76
Average selling price of systems backlog (EUR millions) ⁴	40.0		45.5		40.0		45.5
Value of booked systems (EUR millions) ⁴	904		1,415		3,455		3,816
Net bookings (in units) ⁴	35		43		121		116
Average selling price of booked systems (EUR millions)⁴	25.8		32.9		28.6		32.9
Number of payroll employees in FTEs	11,920		12,933		11,920		12,933
Number of temporary employees in FTEs	2,498		2,599		2,498		2,599

ASML - Summary US GAAP Consolidated Balance Sheets^1,2



	Dec 31,	Oct 2,
	2015	2016
(in millions EUR)

ASSETS
Cash and cash equivalents	2,458.7	2,913.0
Short-term investments	950.0	1,400.0
Accounts receivable, net	803.7	858.4
Finance receivables, net	280.5	663.5
Current tax assets	19.1	143.5
Inventories, net	2,573.7	2,696.9
Deferred tax assets ⁵	133.1	—
Other assets	488.8	540.4
Total current assets	7,707.6	9,215.7

Finance receivables, net	124.0	71.8
Deferred tax assets ⁵	29.0	39.1
Other assets	450.9	623.2
Goodwill	2,624.6	2,571.0
Other intangible assets, net	738.2	694.0
Property, plant and equipment, net	1,620.7	1,587.4
Total non-current assets	5,587.4	5,586.5

Total assets	13,295.0	14,802.2

LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities ⁵	3,107.2	3,272.2

Long-term debt	1,125.5	2,390.6
Deferred and other tax liabilities ⁵	256.7	222.1
Provisions	2.4	16.5
Accrued and other liabilities	414.4	387.6
Total non-current liabilities	1,799.0	3,016.8

Total liabilities	4,906.2	6,289.0

Total shareholders’ equity	8,388.8	8,513.2
Total liabilities and shareholders’ equity	13,295.0	14,802.2

ASML - Summary US GAAP Consolidated Statements of Cash Flows^1,2



	Three months ended,				Nine months ended,
	Sep 27,		Oct 2,		Sep 27,		Oct 2,
	2015		2016		2015		2016
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income	322.4		395.9		1,094.8		947.7

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	77.5		87.7		216.4		253.8
Impairment	0.2		1.4		0.8		2.3
Loss on disposal of property, plant and equipment	0.3		1.7		1.6		3.8
Share-based payments	14.8		11.6		44.4		35.7
Allowance for doubtful receivables	0.6		0.7		2.7		2.4
Allowance for obsolete inventory	56.3		2.9		153.6		62.0
Deferred income taxes	41.0		37.2		48.1		26.1
Changes in assets and liabilities	(93.3	)	(541.8	)	(521.6	)	(861.2	)
Net cash provided by (used in) operating activities	419.8		(2.7	)	1,040.8		472.6

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(86.5	)	(66.3	)	(251.3	)	(220.4	)
Purchase of intangible assets	—		(2.6	)	(1.1	)	(7.5	)
Purchase of available for sale securities	—		(770.0	)	—		(1,470.0	)
Maturity of available for sale securities	25.0		370.0		334.9		1,020.0
Cash from (used for) derivative financial instruments	(37.8	)	(14.4	)	(164.8	)	(5.6	)
Loans issued and other investments	—		(1.2	)	—		(7.2	)
Net cash provided by (used in) investing activities	(99.3	)	(484.5	)	(82.3	)	(690.7	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid	—		—		(302.3	)	(445.9	)
Purchase of shares	(141.5	)	(14.6	)	(424.2	)	(400.0	)
Net proceeds from issuance of shares	9.0		11.7		23.5		34.4
Net proceeds from issuance of notes	—		1,484.7		—		1,484.7
Repayment of debt	(1.0	)	(1.1	)	(2.5	)	(3.5	)
Tax benefit from share-based payments	0.5		0.5		2.9		0.6
Net cash provided by (used in) financing activities	(133.0	)	1,481.2		(702.6	)	670.3

Net cash flows	187.5		994.0		255.9		452.2

Effect of changes in exchange rates on cash	(1.6	)	(7.1	)	5.5		2.1
Net increase (decrease) in cash and cash equivalents	185.9		986.9		261.4		454.3

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations ^1,2



	Three months ended,
		Sep 27,		Dec 31,		Apr 3,		Jul 3,		Oct 2,
		2015		2015		2016		2016		2016
(in millions EUR, except per share data)

Net system sales		975.3		880.9		855.8		1,254.1		1,238.2
Net service and field option sales		573.9		553.3		477.4		485.5		576.4
Total net sales		1,549.2		1,434.2		1,333.2		1,739.6		1,814.6

Total cost of sales		(845.7	)	(774.4	)	(765.1	)	(998.2	)	(980.2	)
Gross profit		703.5		659.8		568.1		741.4		834.4

Other income		20.8		20.8		23.4		23.5		23.4
Research and development costs		(266.3	)	(273.0	)	(274.7	)	(270.3	)	(273.4	)
Selling, general and administrative costs		(85.6	)	(89.5	)	(88.8	)	(90.4	)	(88.8	)
Income from operations		372.4		318.1		228.0		404.2		495.6

Interest and other, net		(4.2	)	(4.6	)	(3.6	)	(3.6	)	(33.9	)
Income before income taxes		368.2		313.5		224.4		400.6		461.7

Benefit from (provision for) income taxes		(45.8	)	(21.1	)	(26.4	)	(46.8	)	(65.8	)
Net income		322.4		292.4		198.0		353.8		395.9


Basic net income per ordinary share		0.75		0.68		0.46		0.83		0.93
Diluted net income per ordinary share ³		0.75		0.68		0.46		0.83		0.93


Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic		429.9		428.8		427.0		424.5		423.8
Diluted ³		432.3		430.8		429.1		426.5		425.8

ASML - Quarterly Summary Ratios and other data ^1,2




	Sep 27,		Dec 31,		Apr 3,		Jul 3,		Oct 2,
	2015		2015		2016		2016		2016
(in millions EUR, except otherwise indicated)

Gross profit as a percentage of net sales	45.4	%	46.0	%	42.6	%	42.6	%	46.0	%
Income from operations as a percentage of net sales	24.0	%	22.2	%	17.1	%	23.2	%	27.3	%
Net income as a percentage of net sales	20.8	%	20.4	%	14.9	%	20.3	%	21.8	%
Income taxes as a percentage of income before income taxes	12.4	%	6.7	%	11.7	%	11.7	%	14.2	%
Shareholders’ equity as a percentage of total assets	64.1	%	63.1	%	63.2	%	61.3	%	57.5	%
Sales of systems (in units)	44		37		33		46		40
Average selling price of system sales (EUR millions)	22.2		23.8		25.9		27.3		31.0
Value of systems backlog (EUR millions) ⁴	2,880		3,184		3,018		3,371		3,462
Systems backlog (in units) ⁴	72		79		76		73		76
Average selling price of systems backlog (EUR millions) ⁴	40.0		40.3		39.7		46.2		45.5
Value of booked systems (EUR millions) ⁴	904		1,184		835		1,566		1,415
Net bookings (in units) ⁴	35		44		30		43		43
Average selling price of booked systems (EUR millions) ⁴	25.8		26.9		27.8		36.4		32.9
Number of payroll employees in FTEs	11,920		12,168		12,407		12,598		12,933
Number of temporary employees in FTEs	2,498		2,513		2,492		2,569		2,599

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets^1,2



	Sep 27,	Dec 31,	Apr 3,	Jul 3,	Oct 2,
	2015	2015	2016	2016	2016
(in millions EUR)

ASSETS
Cash and cash equivalents	2,680.9	2,458.7	2,063.4	1,926.1	2,913.0
Short-term investments	—	950.0	1,075.0	1,000.0	1,400.0
Accounts receivable, net	1,089.4	803.7	753.2	732.4	858.4
Finance receivables, net	453.7	280.5	446.5	524.0	663.5
Current tax assets	42.8	19.1	96.0	178.0	143.5
Inventories, net	2,537.0	2,573.7	2,750.0	2,715.3	2,696.9
Deferred tax assets ⁵	127.6	133.1	—	—	—
Other assets	416.1	488.8	502.1	504.7	540.4
Total current assets	7,347.5	7,707.6	7,686.2	7,580.5	9,215.7

Finance receivables, net	49.8	124.0	102.2	105.7	71.8
Deferred tax assets ⁵	32.8	29.0	47.4	50.0	39.1
Other assets	429.4	450.9	483.8	641.2	623.2
Goodwill	2,574.0	2,624.6	2,537.7	2,603.7	2,571.0
Other intangible assets, net	739.5	738.2	706.0	713.5	694.0
Property, plant and equipment, net	1,532.6	1,620.7	1,580.3	1,608.9	1,587.4
Total non-current assets	5,358.1	5,587.4	5,457.4	5,723.0	5,586.5

Total assets	12,705.6	13,295.0	13,143.6	13,303.5	14,802.2

LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities ⁵	2,711.3	3,107.2	3,246.8	3,720.1	3,272.2

Long-term debt	1,125.3	1,125.5	1,144.3	901.9	2,390.6
Deferred and other tax liabilities ⁵	259.2	256.7	138.0	196.4	222.1
Provisions	2.8	2.4	—	12.6	16.5
Accrued and other liabilities	462.1	414.4	311.1	323.3	387.6
Total non-current liabilities	1,849.4	1,799.0	1,593.4	1,434.2	3,016.8

Total liabilities	4,560.7	4,906.2	4,840.2	5,154.3	6,289.0

Total shareholders’ equity	8,144.9	8,388.8	8,303.4	8,149.2	8,513.2
Total liabilities and shareholders’ equity	12,705.6	13,295.0	13,143.6	13,303.5	14,802.2

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows^1,2



	Three months ended,
		Sep 27,		Dec 31,		Apr 3,		Jul 3,		Oct 2,
		2015		2015		2016		2016		2016
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income		322.4		292.4		198.0		353.8		395.9

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		77.5		80.5		82.0		84.1		87.7
Impairment		0.2		1.5		0.5		0.4		1.4
Loss on disposal of property, plant and equipment		0.3		—		1.2		0.9		1.7
Share-based payments		14.8		14.7		13.2		10.9		11.6
Allowance for doubtful receivables		0.6		1.2		0.9		0.8		0.7
Allowance for obsolete inventory		56.3		58.2		36.6		22.5		2.9
Deferred income taxes		41.0		(2.8	)	(4.5	)	(6.6	)	37.2
Changes in assets and liabilities		(93.3	)	539.0		(333.7	)	14.3		(541.8	)
Net cash provided by (used in) operating activities		419.8		984.7		(5.8	)	481.1		(2.7	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(86.5	)	(120.5	)	(55.2	)	(98.9	)	(66.3	)
Purchase of intangible assets		—		—		(3.6	)	(1.3	)	(2.6	)
Purchase of available for sale securities		—		(950.0	)	(350.0	)	(350.0	)	(770.0	)
Maturity of available for sale securities		25.0		—		225.0		425.0		370.0
Cash from (used for) derivative financial instruments		(37.8	)	(7.1	)	1.1		7.7		(14.4	)
Loans issued and other investments		—		—		—		(6.0	)	(1.2	)
Net cash provided by (used in) investing activities		(99.3	)	(1,077.6	)	(182.7	)	(23.5	)	(484.5	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		—		—		—		(445.9	)	—
Purchase of shares		(141.5	)	(140.7	)	(213.5	)	(171.9	)	(14.6	)
Net proceeds from issuance of shares		9.0		9.7		10.6		12.1		11.7
Net proceeds from issuance of notes		—		—		—		—		1,484.7
Repayment of debt		(1.0	)	(1.1	)	(1.2	)	(1.2	)	(1.1	)
Tax benefit from share-based payments		0.5		0.8		—		0.1		0.5
Net cash provided by (used in) financing activities		(133.0	)	(131.3	)	(204.1	)	(606.8	)	1,481.2

Net cash flows		187.5		(224.2	)	(392.6	)	(149.2	)	994.0

Effect of changes in exchange rates on cash		(1.6	)	2.0		(2.7	)	11.9		(7.1	)
Net increase (decrease) in cash and cash equivalents		185.9		(222.2	)	(395.3	)	(137.3	)	986.9

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of Preparation

The accompanying Consolidated Financial Statements are stated in millions of euros unless indicated otherwise. The accompanying Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP"). Further disclosures, as required under US GAAP in annual reports, are not included in the summary consolidated financial statements.

Use of Estimates

The preparation of our Consolidated Financial Statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of net sales and costs during the reported periods. Actual results could differ from those estimates.

Principles of Consolidation

The Consolidated Financial Statements include the Financial Statements of ASML Holding N.V. and all of its subsidiaries and the variable interest entity of which ASML is the primary beneficiary (referred to as "ASML"). All intercompany profits, balances and transactions have been eliminated in the consolidation. Subsidiaries are all entities over which ASML has the power to govern financial and operating policies generally accompanying a shareholding of more than 50 percent of the outstanding voting rights. As from the date that these criteria are met, the financial data of the relevant subsidiaries are included in the consolidation.

Revenue Recognition

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller‘s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Prior to shipment, systems undergo a "Factory Acceptance Test" in our cleanroom facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue is recognized, only after all contractual specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system’s performance is re-tested upon installation at the customer’s site, we have never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, we initially defer revenue recognition until acceptance of the new technology based system and completion of installation at the customer’s premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely "new" technology occurs infrequently, and in the past 15 years, has occurred on only 2 occasions: 2000 (TWINSCAN) and 2010 (EUV).

We offer customers discounts in the normal course of sales negotiations. These discounts are directly deducted from the gross sales price at the moment of revenue recognition. From time to time, we offer free or discounted products or services (award credits) to our customers as part of a volume purchase agreement. In some instances these volume discounts can be used to purchase field options (system enhancements) and services. The related amount is recorded as a reduction in net sales at time of system shipment. The sales transaction that gives rise to these award credits is accounted for as a multiple element sales transaction as the agreements involve the delivery of multiple products. The consideration received from the sales transaction is allocated between the award credits and the other elements of the sales transaction. The consideration allocated to the award credits is recognized as deferred revenue until award credits are delivered to the customer and earned. The amount allocable to a delivered item is limited to the amount that is not contingent upon the delivery of additional items or meeting other specified performance conditions (the non-contingent amount).

For each of the specified deliverables ASML determines the selling price by using either vendor specific objective evidence (‘VSOE’), third party evidence (‘TPE’) or by best estimate of the selling price (‘BESP’). When we are unable to establish relative selling price using VSOE or TPE, ASML uses BESP in its allocation of arrangement consideration. The total arrangement consideration is allocated at inception of the arrangement to all deliverables on the basis of their relative selling price. The revenue relating to the undelivered elements of the arrangements is deferred at their relative selling prices until delivery of these elements. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract.

For our NXE:3300B and NXE:3350B systems, we are unable to determine VSOE for extended and enhanced (optic) warranty contracts. We determined for NXE:3300B and NXE:3350B systems that BESP is the appropriate reference in the fair value hierarchy for extended and enhanced (optic) warranty contracts. We review selling prices periodically and maintain internal controls over the establishment and updates of these elements.

Foreign currency risk management

Our sales are predominately denominated in euros. Exceptions may occur on a customer by customer basis. Our cost of sales and other expenses are mainly denominated in euros, to a certain extent in US dollars, Taiwanese dollars and Japanese yen and to a limited extent in other currencies. Therefore, we are exposed to foreign currency exchange risks.

It is our policy to hedge material transaction exposures, such as forecasted sales and purchase transactions, and material net remeasurement exposures, such as accounts receivable and payable. We hedge these exposures through the use of foreign exchange contracts.

ASML – Reconciliation US GAAP – IFRS ^1,2



Net income	Three months ended,			Nine months ended,
	Sep 27,	Oct 2,		Sep 27,		Oct 2,
	2015	2016		2015		2016
(in millions EUR)
Net income based on US GAAP	322.4	395.9		1,094.8		947.7
Development expenditures (see Note 1)	57.3	48.6		189.7		173.8
Share-based payments (see Note 2)	0.4	0.1		2.4		0.8
Income taxes (see Note 3)	3.8	(19.1	)	(11.7	)	(95.6	)
Net income based on IFRS	383.9	425.5		1,275.2		1,026.7



Shareholders' equity	Sep 27,	Dec 31,	Apr 3,	Jul 3,		Oct 2,
	2015	2015	2016	2016		2016
(in millions EUR)
Shareholders' equity based on US GAAP	8,144.9	8,388.8	8,303.4	8,149.2		8,513.2
Development expenditures (see Note 1)	995.7	1,054.5	1,091.1	1,178.2		1,221.7
Share-based payments (see Note 2)	18.3	16.5	17.8	17.0		17.9
Income taxes (see Note 3)	32.9	31.4	17.1	(44.9	)	(62.2	)
Equity based on IFRS	9,191.8	9,491.2	9,429.4	9,299.5		9,690.6

Notes to the reconciliation from US GAAP to IFRS

Note 1 Development expenditures

Under US GAAP, ASML applies ASC 730, "Research and Development". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Under IFRS, ASML applies IAS 38, "Intangible Assets". In accordance with IAS 38, ASML capitalizes certain development expenditures that are amortized over the expected useful life of the related product generally ranging between one and five years. Amortization starts when the developed product is ready for volume production.

Note 2 Share-based Payments

Under US GAAP, ASML applies ASC 718 "Compensation - Stock Compensation" which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as we recognize compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under US GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in ASML’s share price do not affect the deferred tax asset recorded in our financial statements.

Under IFRS, ASML applies IFRS 2, "Share-based Payments". In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and shares granted to its employees. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in ASML’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

Note 3 Income taxes

Under US GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under US GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

Under IFRS, ASML applies IAS 12, "Income Taxes". In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.


¹	These financial statements are unaudited.


²	Numbers have been rounded.

The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.


⁴	Our systems backlog and net bookings include all system sales orders for which written authorizations have been accepted (for EUV starting as of the NXE:3350B).


⁵	As of January 1, 2016 ASML early adopted the amendment to ASC 740 “Income taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which requires that deferred tax liabilities and assets are classified as non-current in the consolidated balance sheets. The comparative figures have not been adjusted to reflect this change in accounting policy.

Exhibit 99.4

ASML - Summary IFRS Consolidated Statement of Profit or Loss ^1,2



	Three months ended,				Nine months ended,
	Sep 27,		Oct 2,		Sep 27,		Oct 2,
	2015		2016		2015		2016
(in millions EUR)

Net system sales	975.3		1,238.2		3,356.3		3,348.1
Net service and field option sales	573.9		576.4		1,496.9		1,539.3
Total net sales	1,549.2		1,814.6		4,853.2		4,887.4

Total cost of sales	(860.0	)	(1,016.4	)	(2,662.1	)	(2,818.9	)
Gross profit	689.2		798.2		2,191.1		2,068.5

Other income	20.8		23.4		62.4		70.3
Research and development costs	(179.5	)	(176.4	)	(520.4	)	(527.4	)
Selling, general and administrative costs	(85.2	)	(88.8	)	(255.8	)	(267.8	)
Operating income	445.3		556.4		1,477.3		1,343.6

Interest and other, net	(4.3	)	(30.1	)	(6.3	)	(30.4	)
Income before income taxes	441.0		526.3		1,471.0		1,313.2

Income tax expense	(57.1	)	(100.8	)	(195.8	)	(286.5	)
Net income	383.9		425.5		1,275.2		1,026.7

ASML - Summary IFRS Consolidated Statement of Financial Position ^1,2



	Dec 31,	Oct 2,
	2015	2016
(in millions EUR)

ASSETS
Property, plant and equipment	1,620.7	1,587.4
Goodwill	2,647.8	2,593.8
Other intangible assets	2,018.5	2,192.5
Deferred tax assets	139.6	168.6
Finance receivables	124.0	71.8
Derivative financial instruments	81.8	104.8
Other assets	369.1	369.7
Total non-current assets	7,001.5	7,088.6

Inventories	2,573.7	2,696.9
Current tax assets	19.1	143.5
Derivative financial instruments	52.0	48.4
Finance receivables	280.5	663.5
Accounts receivable	803.7	858.4
Other assets	375.6	417.5
Short-term investments	950.0	1,400.0
Cash and cash equivalents	2,458.7	2,913.0
Total current assets	7,513.3	9,141.2

Total assets	14,514.8	16,229.8

EQUITY AND LIABILITIES
Equity	9,491.2	9,690.6

Long-term debt	1,125.5	2,390.6
Derivative financial instruments	1.9	0.8
Deferred and other tax liabilities	376.5	472.4
Provisions	2.4	16.5
Accrued and other liabilities	412.5	386.7
Total non-current liabilities	1,918.8	3,267.0

Provisions	2.4	2.4
Derivative financial instruments	19.0	29.8
Current portion of long-term debt	4.2	250.4
Current and other tax liabilities	3.7	131.1
Accrued and other liabilities	2,547.6	2,227.2
Accounts payable	527.9	631.3
Total current liabilities	3,104.8	3,272.2

Total equity and liabilities	14,514.8	16,229.8

ASML - Summary IFRS Consolidated Statement of Cash Flows ^1,2



	Three months ended,				Nine months ended,
	Sep 27,		Oct 2,		Sep 27,		Oct 2,
	2015		2016		2015		2016
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income	383.9		425.5		1,275.2		1,026.7

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	91.9		124.0		261.5		329.2
Impairment	0.2		1.4		0.8		2.3
Loss on disposal of property, plant and equipment	0.3		1.7		1.6		3.8
Share-based payments	9.9		12.6		37.5		36.7
Allowance for doubtful receivables	0.6		0.7		2.7		2.4
Allowance for obsolete inventory	56.3		2.9		153.6		62.0
Deferred income taxes	59.4		67.1		114.3		172.1
Changes in assets and liabilities	(95.8	)	(537.3	)	(522.2	)	(860.6	)
Net cash provided by (used in) operating activities	506.7		98.6		1,325.0		774.6

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(86.5	)	(66.3	)	(251.3	)	(220.4	)
Purchase of intangible assets	(86.4	)	(103.4	)	(282.4	)	(308.9	)
Purchase of available for sale securities	—		(770.0	)	—		(1,470.0	)
Maturity of available for sale securities	25.0		370.0		334.9		1,020.0
Cash from (used for) derivative financial instruments	(37.8	)	(14.4	)	(164.8	)	(5.6	)
Loans issued and other investments	—		(1.2	)	—		(7.2	)
Net cash provided by (used in) investing activities	(185.7	)	(585.3	)	(363.6	)	(992.1	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid	—		—		(302.3	)	(445.9	)
Purchase of shares	(141.5	)	(14.6	)	(424.2	)	(400.0	)
Net proceeds from issuance of shares	9.0		11.7		23.5		34.4
Net proceeds from issuance of notes	—		1,484.7		—		1,484.7
Repayment of debt	(1.0	)	(1.1	)	(2.5	)	(3.5	)
Net cash provided by (used in) financing activities	(133.5	)	1,480.7		(705.5	)	669.7

Net cash flows	187.5		994.0		255.9		452.2

Effect of changes in exchange rates on cash	(1.6	)	(7.1	)	5.5		2.1
Net increase (decrease) in cash and cash equivalents	185.9		986.9		261.4		454.3

ASML - Quarterly Summary IFRS Consolidated Statement of Profit or Loss ^1,2



	Three months ended,
		Sep 27,		Dec 31,		Apr 3,		Jul 3,		Oct 2,
		2015		2015		2016		2016		2016
(in millions EUR)

Net system sales		975.3		880.9		855.8		1,254.1		1,238.2
Net service and field option sales		573.9		553.3		477.4		485.5		576.4
Total net sales		1,549.2		1,434.2		1,333.2		1,739.6		1,814.6

Total cost of sales		(860.0	)	(792.2	)	(784.4	)	(1,018.1	)	(1,016.4	)
Gross profit		689.2		642.0		548.8		721.5		798.2

Other income		20.8		20.8		23.4		23.5		23.4
Research and development costs		(179.5	)	(189.8	)	(199.1	)	(151.9	)	(176.4	)
Selling, general and administrative costs		(85.2	)	(89.5	)	(88.7	)	(90.3	)	(88.8	)
Operating income		445.3		383.5		284.4		502.8		556.4

Interest and other, net		(4.3	)	1.6		(0.3	)	—		(30.1	)
Income before income taxes		441.0		385.1		284.1		502.8		526.3

Income tax expense		(57.1	)	(40.8	)	(53.3	)	(132.4	)	(100.8	)
Net income		383.9		344.3		230.8		370.4		425.5

ASML - Quarterly Summary IFRS Consolidated Statement of Financial Position^1,2



	Sep 27,	Dec 31,	Apr 3,	Jul 3,	Oct 2,
	2015	2015	2016	2016	2016
(in millions EUR)

ASSETS
Property, plant and equipment	1,532.6	1,620.7	1,580.3	1,608.9	1,587.4
Goodwill	2,596.8	2,647.8	2,560.3	2,626.8	2,593.8
Other intangible assets	1,942.7	2,018.5	2,033.0	2,153.0	2,192.5
Deferred tax assets	147.2	139.6	123.4	165.2	168.6
Finance receivables	49.8	124.0	102.2	105.7	71.8
Derivative financial instruments	82.9	81.8	118.2	121.5	104.8
Other assets	346.5	369.1	365.6	367.5	369.7
Total non-current assets	6,698.5	7,001.5	6,883.0	7,148.6	7,088.6

Inventories	2,537.0	2,573.7	2,750.0	2,715.3	2,696.9
Current tax assets	42.8	19.1	96.0	178.0	143.5
Derivative financial instruments	52.1	52.0	56.8	43.0	48.4
Finance receivables	453.7	280.5	446.5	524.0	663.5
Accounts receivable	1,089.4	803.7	753.2	732.4	858.4
Other assets	302.7	375.6	386.3	395.0	417.5
Short-term investments	—	950.0	1,075.0	1,000.0	1,400.0
Cash and cash equivalents	2,680.9	2,458.7	2,063.4	1,926.1	2,913.0
Total current assets	7,158.6	7,513.3	7,627.2	7,513.8	9,141.2

Total assets	13,857.1	14,514.8	14,510.2	14,662.4	16,229.8

EQUITY AND LIABILITIES
Equity	9,191.8	9,491.2	9,429.4	9,299.5	9,690.6

Long-term debt	1,125.3	1,125.5	1,144.3	901.9	2,390.6
Derivative financial instruments	2.1	1.9	1.4	1.2	0.8
Deferred and other tax liabilities	363.9	376.5	378.6	405.0	472.4
Provisions	2.8	2.4	—	12.6	16.5
Accrued and other liabilities	460.0	412.5	309.7	322.1	386.7
Total non-current liabilities	1,954.1	1,918.8	1,834.0	1,642.8	3,267.0

Provisions	2.4	2.4	4.0	2.9	2.4
Derivative financial instruments	18.4	19.0	24.8	34.3	29.8
Current portion of long-term debt	4.2	4.2	4.2	253.6	250.4
Current and other tax liabilities	1.6	3.7	8.6	170.9	131.1
Accrued and other liabilities	2,057.8	2,547.6	2,560.7	2,524.2	2,227.2
Accounts payable	626.8	527.9	644.5	734.2	631.3
Total current liabilities	2,711.2	3,104.8	3,246.8	3,720.1	3,272.2

Total equity and liabilities	13,857.1	14,514.8	14,510.2	14,662.4	16,229.8

ASML - Quarterly Summary IFRS Consolidated Statement of Cash Flows ^1,2



	Three months ended,
		Sep 27,		Dec 31,		Apr 3,		Jul 3,		Oct 2,
		2015		2015		2016		2016		2016
(in millions EUR)

CASH FLOWS FROM OPERATING ACTIVITIES
Net income		383.9		344.3		230.8		370.4		425.5

Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		91.9		98.4		101.3		103.9		124.0
Impairment		0.2		1.5		0.5		0.4		1.4
Loss on disposal of property, plant and equipment		0.3		—		1.2		0.9		1.7
Share-based payments		9.9		12.6		13.6		10.5		12.6
Allowance for doubtful receivables		0.6		1.2		0.9		0.8		0.7
Allowance for obsolete inventory		56.3		58.2		36.6		22.5		2.9
Deferred income taxes		59.4		20.5		23.1		81.9		67.1
Changes in assets and liabilities		(95.8	)	537.8		(335.2	)	11.9		(537.3	)
Net cash provided by (used in) operating activities		506.7		1,074.5		72.8		603.2		98.6

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(86.5	)	(120.5	)	(55.2	)	(98.9	)	(66.3	)
Purchase of intangible assets		(86.4	)	(89.0	)	(82.2	)	(123.3	)	(103.4	)
Purchase of available for sale securities		—		(950.0	)	(350.0	)	(350.0	)	(770.0	)
Maturity of available for sale securities		25.0		—		225.0		425.0		370.0
Cash from (used for) derivative financial instruments		(37.8	)	(7.1	)	1.1		7.7		(14.4	)
Loans issued and other investments		—		—		—		(6.0	)	(1.2	)
Net cash provided by (used in) investing activities		(185.7	)	(1,166.6	)	(261.3	)	(145.5	)	(585.3	)

CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		—		—		—		(445.9	)	—
Purchase of shares		(141.5	)	(140.7	)	(213.5	)	(171.9	)	(14.6	)
Net proceeds from issuance of shares		9.0		9.7		10.6		12.1		11.7
Net proceeds from issuance of notes		—		—		—		—		1,484.7
Repayment of debt		(1.0	)	(1.1	)	(1.2	)	(1.2	)	(1.1	)
Net cash provided by (used in) financing activities		(133.5	)	(132.1	)	(204.1	)	(606.9	)	1,480.7

Net cash flows		187.5		(224.2	)	(392.6	)	(149.2	)	994.0

Effect of changes in exchange rates on cash		(1.6	)	2.0		(2.7	)	11.9		(7.1	)
Net increase (decrease) in cash and cash equivalents		185.9		(222.2	)	(395.3	)	(137.3	)	986.9

Notes to the Summary IFRS Consolidated Financial Statements

Basis of Preparation

The accompanying Consolidated Financial Statements are stated in millions of euros unless indicated otherwise.

The accompanying Consolidated Financial Statements have been prepared in conformity with International Financial Reporting Standards as adopted by the EU (“IFRS”) accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included in the summary consolidated financial statements.

For internal and external reporting purposes, we apply accounting principles generally accepted in the United States of America ("US GAAP"). US GAAP is our primary accounting standard for the setting of financial and operational performance targets.

Use of Estimates

The preparation of our Consolidated Financial Statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of net sales and costs during the reported periods. Actual results could differ from those estimates.

Basis of Consolidation

The Consolidated Financial Statements include the Financial Statements of ASML Holding N.V. and all of its subsidiaries and the special purpose entity of which ASML is the primary beneficiary (referred to as "ASML"). All intercompany profits, balances and transactions have been eliminated in the consolidation. Subsidiaries are all entities over which ASML has the power to govern financial and operating policies generally accompanying a shareholding of more than 50 percent of the outstanding voting rights. As from the date that these criteria are met, the financial data of the relevant subsidiaries are included in the consolidation.

Revenue Recognition

The main portion of our net sales is derived from contractual arrangements with our customers that have multiple deliverables (elements), which mainly include the sale of our systems, installation and training services and extended and enhanced (optic) warranty contracts. The requirements for establishing separate units of accounting in a multiple element arrangement require that the allocation of arrangement consideration to each deliverable is based on the relative selling price of the deliverable. The revenue relating to the undelivered elements of the arrangements is deferred until delivery of these elements. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract.

Foreign currency risk management

ASML – Reconciliation US GAAP – IFRS ^1,2



Net income	Three months ended,			Nine months ended,
	Sep 27,	Oct 2,		Sep 27,		Oct 2,
	2015	2016		2015		2016
(in millions EUR)
Net income based on US GAAP	322.4	395.9		1,094.8		947.7
Development expenditures (see Note 1)	57.3	48.6		189.7		173.8
Share-based payments (see Note 2)	0.4	0.1		2.4		0.8
Income taxes (see Note 3)	3.8	(19.1	)	(11.7	)	(95.6	)
Net income based on IFRS	383.9	425.5		1,275.2		1,026.7



Shareholders' equity	Sep 27,	Dec 31,	Apr 3,	Jul 3,		Oct 2,
	2015	2015	2016	2016		2016
(in millions EUR)
Shareholders' equity based on US GAAP	8,144.9	8,388.8	8,303.4	8,149.2		8,513.2
Development expenditures (see Note 1)	995.7	1,054.5	1,091.1	1,178.2		1,221.7
Share-based payments (see Note 2)	18.3	16.5	17.8	17.0		17.9
Income taxes (see Note 3)	32.9	31.4	17.1	(44.9	)	(62.2	)
Equity based on IFRS	9,191.8	9,491.2	9,429.4	9,299.5		9,690.6

Notes to the reconciliation from US GAAP to IFRS

Note 1 Development expenditures

Under US GAAP, ASML applies ASC 730, "Research and Development". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 2 Share-based Payments

Note 3 Income taxes


¹	These financial statements are unaudited.


²	Numbers have been rounded.

StreetInsider

Log in to your account:

Form 6-K ASML HOLDING NV For: Oct 19

Categories

Next Articles